UBS Group’s BioNexus Gene Lab BGLC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.4K | Buy |
+9,562
| New | +$29.4K | ﹤0.01% | 6869 |
|
|
2025
Q1 | – | Sell |
-10,963
| Closed | -$30.7K | – | 8841 |
|
|
2024
Q4 | $30.7K | Buy |
10,963
+2,632
| +32% | +$7.37K | ﹤0.01% | 6360 |
|
|
2024
Q3 | $37.1K | Buy |
+8,331
| New | +$37.1K | ﹤0.01% | 5812 |
|
|
2024
Q2 | – | Sell |
-842
| Closed | -$5.94K | – | 8341 |
|
|
2024
Q1 | $5.94K | Buy |
+842
| New | +$5.94K | ﹤0.01% | 6324 |
|